The global oral solid dosage pharmaceutical formulation market is moving into a phase of steady, innovation-led expansion as patients, healthcare providers, and drug manufacturers continue to prioritize convenient, affordable, and reliable medication delivery. Valued at US$ 654.6 Mn in 2023, the market is projected to expand at a CAGR of 5.2% from 2024 to 2034, reaching approximately US$ 1.1 Bn...
